Roivant Sciences Stock Return On Equity

ROIV Stock

USD 12.53 0.71 6.01%

Roivant Sciences fundamentals help investors to digest information that contributes to Roivant Sciences' financial success or failures. It also enables traders to predict the movement of Roivant Stock. The fundamental analysis module provides a way to measure Roivant Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Roivant Sciences stock.

		Last Reported	Projected for Next Year
	Return On Equity	0.73	0.77

Return On Equity is likely to climb to 0.77 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Roivant Sciences Company Return On Equity Analysis

Roivant Sciences' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Roivant Sciences Return On Equity

1.29

Most of Roivant Sciences' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Roivant Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Roivant Return On Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for Roivant Sciences is extremely important. It helps to project a fair market value of Roivant Stock properly, considering its historical fundamentals such as Return On Equity. Since Roivant Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Roivant Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Roivant Sciences' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Property Plant Equipment	Long Term Debt	Short Term Investments	Deferred Long Term Liab	Net Invested Capital	Long Term Investments	Net Working Capital	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Intangible Assets
Total Assets		1.0	0.49	0.4	-0.99	0.86	0.78	0.96	0.69	1.0	0.03	0.53	0.8	-0.76	0.66	0.81	-0.79	0.81	0.77	0.89	-0.94	-0.82
Total Stockholder Equity	1.0		0.51	0.34	-1.0	0.9	0.74	0.95	0.63	1.0	-0.04	0.54	0.76	-0.72	0.61	0.81	-0.81	0.82	0.74	0.87	-0.94	-0.82
Net Tangible Assets	0.49	0.51		0.58	-0.51	0.41	0.48	0.3	0.18	0.47	-0.39	0.9	0.23	-0.39	0.35	0.15	-0.09	0.15	0.17	0.21	-0.24	-0.33
Current Deferred Revenue	0.4	0.34	0.58		-0.35	-0.08	0.75	0.37	0.69	0.35	0.41	0.51	0.6	-0.81	0.78	0.03	0.16	0.04	0.52	0.39	-0.17	-0.25
Net Debt	-0.99	-1.0	-0.51	-0.35		-0.89	-0.77	-0.94	-0.65	-1.0	0.04	-0.55	-0.77	0.73	-0.64	-0.84	0.78	-0.84	-0.75	-0.88	0.95	0.78
Retained Earnings	0.86	0.9	0.41	-0.08	-0.89		0.41	0.79	0.27	0.88	-0.34	0.45	0.46	-0.35	0.25	0.79	-0.89	0.8	0.46	0.67	-0.87	-0.74
Accounts Payable	0.78	0.74	0.48	0.75	-0.77	0.41		0.74	0.9	0.75	0.28	0.5	0.9	-0.92	0.96	0.67	-0.29	0.68	0.86	0.84	-0.71	-0.39
Net Receivables	0.96	0.95	0.3	0.37	-0.94	0.79	0.74		0.77	0.96	0.27	0.42	0.88	-0.76	0.65	0.79	-0.83	0.79	0.87	0.95	-0.94	-0.81
Total Liab	0.69	0.63	0.18	0.69	-0.65	0.27	0.9	0.77		0.66	0.63	0.33	0.96	-0.87	0.87	0.6	-0.36	0.59	0.94	0.87	-0.66	-0.39
Total Current Assets	1.0	1.0	0.47	0.35	-1.0	0.88	0.75	0.96	0.66		0.01	0.51	0.78	-0.74	0.63	0.82	-0.81	0.82	0.76	0.88	-0.95	-0.82
Short Term Debt	0.03	-0.04	-0.39	0.41	0.04	-0.34	0.28	0.27	0.63	0.01		-0.19	0.54	-0.41	0.38	-0.04	-0.01	-0.05	0.56	0.36	-0.05	-0.06
Property Plant Equipment	0.53	0.54	0.9	0.51	-0.55	0.45	0.5	0.42	0.33	0.51	-0.19		0.36	-0.34	0.29	0.26	-0.27	0.26	0.35	0.36	-0.33	-0.3
Long Term Debt	0.8	0.76	0.23	0.6	-0.77	0.46	0.9	0.88	0.96	0.78	0.54	0.36		-0.89	0.87	0.72	-0.51	0.71	0.99	0.95	-0.79	-0.5
Short Term Investments	-0.76	-0.72	-0.39	-0.81	0.73	-0.35	-0.92	-0.76	-0.87	-0.74	-0.41	-0.34	-0.89		-0.96	-0.52	0.29	-0.53	-0.82	-0.79	0.66	0.56
Deferred Long Term Liab	0.66	0.61	0.35	0.78	-0.64	0.25	0.96	0.65	0.87	0.63	0.38	0.29	0.87	-0.96		0.56	-0.14	0.57	0.82	0.77	-0.61	-0.32
Net Invested Capital	0.81	0.81	0.15	0.03	-0.84	0.79	0.67	0.79	0.6	0.82	-0.04	0.26	0.72	-0.52	0.56		-0.71	1.0	0.74	0.88	-0.94	-0.43
Long Term Investments	-0.79	-0.81	-0.09	0.16	0.78	-0.89	-0.29	-0.83	-0.36	-0.81	-0.01	-0.27	-0.51	0.29	-0.14	-0.71		-0.71	-0.54	-0.7	0.84	0.8
Net Working Capital	0.81	0.82	0.15	0.04	-0.84	0.8	0.68	0.79	0.59	0.82	-0.05	0.26	0.71	-0.53	0.57	1.0	-0.71		0.74	0.87	-0.94	-0.43
Long Term Debt Total	0.77	0.74	0.17	0.52	-0.75	0.46	0.86	0.87	0.94	0.76	0.56	0.35	0.99	-0.82	0.82	0.74	-0.54	0.74		0.96	-0.8	-0.46
Capital Surpluse	0.89	0.87	0.21	0.39	-0.88	0.67	0.84	0.95	0.87	0.88	0.36	0.36	0.95	-0.79	0.77	0.88	-0.7	0.87	0.96		-0.93	-0.59
Short Long Term Debt	-0.94	-0.94	-0.24	-0.17	0.95	-0.87	-0.71	-0.94	-0.66	-0.95	-0.05	-0.33	-0.79	0.66	-0.61	-0.94	0.84	-0.94	-0.8	-0.93		0.7
Intangible Assets	-0.82	-0.82	-0.33	-0.25	0.78	-0.74	-0.39	-0.81	-0.39	-0.82	-0.06	-0.3	-0.5	0.56	-0.32	-0.43	0.8	-0.43	-0.46	-0.59	0.7

Click cells to compare fundamentals

For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

Competition

Predict Roivant Sciences

Return On Equity Over Time

Roivant Total Stockholder Equity

Total Stockholder Equity

6.27 Billion

At this time, Roivant Sciences' Total Stockholder Equity is fairly stable compared to the past year.

Based on the latest financial disclosure, Roivant Sciences has a Return On Equity of 1.2896. This is 105.38% lower than that of the Biotechnology sector and 103.54% lower than that of the Health Care industry. The return on equity for all United States stocks is notably lower than that of the firm.

Roivant Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Roivant Sciences' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Roivant Sciences could also be used in its relative valuation, which is a method of valuing Roivant Sciences by comparing valuation metrics of similar companies.

Roivant Sciences is currently under evaluation in return on equity category among its peers.

Roivant Sciences ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Roivant Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Roivant Sciences' managers, analysts, and investors.

Environmental

Governance

Social

Roivant Fundamentals

	Return On Equity	1.29
	Return On Asset	-0.18
	Profit Margin	37.25 %
	Operating Margin	(74.46) %
	Current Valuation	3.79 B
	Shares Outstanding	727.95 M
	Shares Owned By Insiders	29.55 %
	Shares Owned By Institutions	79.46 %
	Number Of Shares Shorted	46.57 M
	Price To Book	1.77 X
	Price To Sales	70.64 X
	Revenue	124.8 M
	Gross Profit	(477.06 M)
	EBITDA	4.31 B
	Net Income	4.23 B
	Cash And Equivalents	1.94 B
	Cash Per Share	2.76 X
	Total Debt	499.75 M
	Debt To Equity	0.28 %
	Current Ratio	6.20 X
	Book Value Per Share	7.03 X
	Cash Flow From Operations	(765.27 M)
	Short Ratio	11.66 X
	Earnings Per Share	5.54 X
	Target Price	16.21
	Number Of Employees	908
	Beta	1.24
	Market Capitalization	9.12 B
	Total Asset	7.22 B
	Retained Earnings	576.17 M
	Working Capital	6.47 B
	Net Asset	7.22 B

About Roivant Sciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Roivant Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Roivant Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Roivant Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Roivant Stock Analysis

When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC